The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
Carrot
I report facts only. Once. I have no need to comment on anyone else's posts apart from yours, for often stated reasons that I cannot be bothered to repeat. Jealous of you? I think not
Keep ramping.
Carrot
I am proud to be included in your comments. I have only at any time written verifiable facts on this board. In English, without idiotic stars, exclamation marks, capitals, etc,. and all the other childish rubbish that is repeated endlessly and which readers find so irritating. As a ramper you have so much to learn.
Carrot
"You really need to stop posting complete and utter rubbish on this bb " - as opposed to half understood chunks of c&p?
Pots and kettles perhaps?
Carrot
As TG2D states; this really is desperate stuff, and not helped by your response. Have you ever thought about not posting? Remember the old adage; do not open mouth until brain is in gear. The same applies to posting.
Verbal diarrhoea, on and on and on with the same half digested facts. The Lucci paper is 3 years old. Who do you ramp for? Or is there an insatiable need to see yourself on the board upwards of 5 time a day? Pitiful.
Thompi
Sure, I appreciate that Parsortix is being used in the research setting for ovarian, lung, prostate, ? also NSCLC, with good results. When I mentioned a one trick pony, it was in reference to the FDA approval. I do not understand why the FDA should limit approval in this way, but such it is. Cynic that I am, I just wonder how easier it might have been for an American firm.
I understand that the hoops that have to be gone through for further approvals are much less onerous than the huge amount required for the initial approval for Ca breast, and I wonder why AGL have not done this. Cost perhaps?. I live in hope for AGL, but optimism thin just now.
Moab